Pharma Industries 2 biggies Torrent Pharma and Sun Pharma have published their quarterly result numbers. Have a look on results highlights along with a technical view on the stock.
Torrent Pharma Q4 Result highlights
•Net Sales at Rs 1,946.00 crore in March 2020 up 4.85% from Rs. 1,856.00 crore in March 2019..
•Quarterly Net Profit at Rs. 314.00 crores in March 2020 up 306.58% from Rs. 152.00 crore in March 2019.
•EBITDA stands at Rs. 563.00 crores in March 2020 up 14.9% from Rs. 490.00 crore in March 2019.
Impact of result on Torrent Pharma
The company has reported good quarterly numbers.
Hurdle around 2635 breaks and sustain above 2635 will see upside movement till 3900 +++ levels in the coming days.
Support around 2250, breaks below 2250 will take it to 1950 levels in the coming days.
Sun Pharma Q4 Results Highlights
♦Consolidated profit of Rs 399.8 crore for the quarter ended March 2020, declining 37.1 percent YoY.
♦Consolidated revenue during the quarter rose 14.3 percent YoY to Rs 8,184.9 crore.
♦EBITDA grew by 34 percent to Rs 1,363 crore and margin expanded by 250 bps to 16.7 percent.
♦For the year FY 2019-20, Sun Pharma has reported a 41.3 percent growth in profit at Rs 3,764.93 crore and a 13 percent increase in revenue at Rs 32,837.5 crore compared to the previous year.
Impact of result on Sun Pharma
The company has reported a good set of numbers.
Hurdle around 476, breaks, and sustain above 476 will see upside movement till 500 +++ levels in the coming days.
Support around 433, breaks below 433 will see downside rally till 400 levels in days to come.